Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -15.73% and Operating profit at -21.89% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -17.54
- NET PROFIT(9M) At USD -73.56 MM has Grown at -399.44%
- DEBT-EQUITY RATIO (HY) Highest at 298.72 %
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
Computers - Software & Consulting
USD 71 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
2.56
-127.93%
0.98
Total Returns (Price + Dividend) 
Cibus, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance
Cibus, Inc. reported net sales of USD 1.97 million for the first half of the year, reflecting a 42.23% growth. However, the company faces challenges with a net profit of USD -50.85 million and a high debt-equity ratio of 298.72%, indicating financial instability amid significant stock volatility.
Read MoreIs Cibus, Inc. technically bullish or bearish?
As of 3 September 2025, the technical trend for Cibus, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including bearish signals from the daily moving averages, weekly KST, and monthly Dow Theory. While the weekly MACD shows a mildly bullish signal, the overall trend remains negative due to the bearish signals from Bollinger Bands and the monthly KST. In terms of performance, Cibus has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -51.44% compared to the S&P's 12.22%, and a one-year return of -62.45% versus the S&P's 17.14%....
Read MoreIs Cibus, Inc. overvalued or undervalued?
As of 21 March 2024, the valuation grade for Cibus, Inc. has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.81 and an EV to EBITDA ratio of -3.40, which suggests that the market may not be accurately reflecting its financial health. Additionally, the Return on Capital Employed (ROCE) stands at a troubling -30.49%, further underscoring the company's challenges. In comparison to its peers, Cibus, Inc. has a negative P/E ratio of -0.7651, while MediaAlpha, Inc. has a P/E of 14.7844, and OneSpan, Inc. shows a more favorable P/E of 9.8867, highlighting the relative weakness of Cibus in the industry. The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -51.44% compared to the index's 12.22%, and a s...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 13 Schemes (22.21%)
Held by 19 Foreign Institutions (0.57%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 12.50% vs 300.00% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 6.67% vs -39.02% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 138.89% vs 800.00% in Dec 2023
YoY Growth in year ended Dec 2024 is 16.26% vs -1,897.63% in Dec 2023






